Tudor Investment Corp
SCLN

Tudor Investment Corp’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Tudor Investment Corp’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-32,200
Closed -$316K – 1579
2017
Q1 		$316K Buy
+32,200
New +$322K 0.01% 967
2016
Q2 		– Sell
-70,121
Closed -$771K – 2079
2016
Q1 		$771K Buy
70,121
+2,543
+4% +$22.6K 0.02% 667
2015
Q4 		$622K Sell
67,578
-17,893
-21% -$150K 0.02% 732
2015
Q3 		$593K Buy
85,471
+57,161
+202% +$490K 0.02% 676
2015
Q2 		$278K Sell
28,310
-6,745
-19% -$61.4K 0.01% 1144
2015
Q1 		$311K Sell
35,055
-6,119
-15% -$48.7K 0.01% 1028
2014
Q4 		$361K Sell
41,174
-879
-2% -$7.12K 0.01% 934
2014
Q3 		$290K Buy
+42,053
New +$252K 0.01% 1029
2014
Q1 		– Sell
-35,700
Closed -$180K – 1523
2013
Q4 		$180K Buy
35,700
+7,600
+27% +$36.6K 0.01% 1125
2013
Q3 		$142K Buy
28,100
+2,300
+9% +$12.8K 0.01% 763
2013
Q2 		$128K Buy
+25,800
New +$123K 0.01% 758

Other funds holding SCLN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tudor Investment Corp's SCLN Position: Q2 2017 in Review

Tudor Investment Corp sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q2 2017, closing a stake of 32,200 shares — an estimated $316K sold.

Tudor Investment Corp first reported a position in SCLN in Q2 2013 and held it in 11 quarters. The position peaked at $771K in Q1 2016. 142 funds tracked by Wall St. Rank hold SCLN as of Q2 2017.

  • Tudor Investment Corp reported no remaining Sciclone Pharmaceuticals Inc position as of Q2 2017 after selling out during the quarter.
  • Tudor Investment Corp sold 32,200 Sciclone Pharmaceuticals Inc shares in Q2 2017, an estimated $316K.
  • Tudor Investment Corp first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 11 quarters.
  • Tudor Investment Corp's Sciclone Pharmaceuticals Inc position peaked at $771K in Q1 2016.
  • 142 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q2 2017.

Based on Tudor Investment Corp's 13F filing for Q2 2017, filed 14 Aug 2017.